TNFα-induced MUC4 elicits trastuzumab resistance in ErbB-2-positive breast cancer

被引：0
|
作者：
Mercogliano, Maria F. [1 ]
De Martino, Mara [1 ]
Venturutti, Leandro [1 ]
Rivas, Martin A. [2 ]
Inurrigarro, Gloria [3 ]
Frahm, Isabel [3 ]
Proietti, Cecilia J. [1 ]
Izzo, Franco [1 ]
Elizade, Patricia V. [1 ]
Schillaci, Roxana [1 ]
机构：
[1] IBYME CONICET, CABA, Buenos Aires, DF, Argentina
[2] Weill Cornell Med Coll, New York, NY USA
[3] Sanatorio Mater Dei, Serv Patol, CABA, Buenos Aires, DF, Argentina
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-712
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
712
引用
收藏
页数：2
相关论文
共 50 条
  • [21] MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1
    L Venturutti
    R I Cordo Russo
    M A Rivas
    M F Mercogliano
    F Izzo
    R H Oakley
    M G Pereyra
    M De Martino
    C J Proietti
    P Yankilevich
    J C Roa
    P Guzmán
    E Cortese
    D H Allemand
    T H Huang
    E H Charreau
    J A Cidlowski
    R Schillaci
    P V Elizalde
    Oncogene, 2016, 35 : 6189 - 6202
  • [22] Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression
    Li, Guangchao
    Zhao, Likun
    Li, Wei
    Fan, Kexing
    Qian, Weizhu
    Hou, Sheng
    Wang, Hao
    Dai, Jianxin
    Wei, Huafeng
    Guo, Yajun
    ONCOTARGET, 2014, 5 (18) : 8317 - 8329
  • [23] Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
    Pandya, K.
    Meeke, K.
    Clementz, A. G.
    Rogowski, A.
    Roberts, J.
    Miele, L.
    Albain, K. S.
    Osipo, C.
    BRITISH JOURNAL OF CANCER, 2011, 105 (06) : 796 - 806
  • [24] Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin
    S Bafna
    S Kaur
    N Momi
    S K Batra
    British Journal of Cancer, 2009, 101 : 1155 - 1161
  • [25] The Membrane Mucin Muc4 Inhibits Apoptosis Induced by Multiple Insults via ErbB2-Dependent and ErbB2-Independent Mechanisms
    Workman, Heather C.
    Sweeney, Colleen
    Carraway, Kermit L., III
    CANCER RESEARCH, 2009, 69 (07) : 2845 - 2852
  • [26] LAPATINIB DITOSYLATE: EXPANDING THERAPEUTIC OPTIONS FOR RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2-POSITIVE BREAST CANCER
    Awada, A.
    Saliba, W.
    Bozovic-Spasojevic, I.
    DRUGS OF TODAY, 2011, 47 (05) : 335 - 345
  • [27] Treatment of metastatic ErbB2-positive breast cancer: Options after progression on trastuzumab
    Spector, Neil
    CLINICAL BREAST CANCER, 2008, 8 : S94 - S99
  • [28] New therapeutic approach for triple negative breast cancer: soluble TNFα blockade and MUC4 expression as a prognostic biomarker
    Mauro, Florencia
    Bruni, Sofia
    Dupont, Agustina
    Inurrigarro, Gloria
    Figurelli, Silvina
    Barchuk, Sabrina
    Della Vecchia, Daniel Lopez
    Russo, Rosalia Cordo
    Deza, Ernesto Gil
    Mercogliano, Maria Florencia
    Schillaci, Roxana
    CANCER RESEARCH, 2023, 83 (07)
  • [29] Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
    K Pandya
    K Meeke
    A G Clementz
    A Rogowski
    J Roberts
    L Miele
    K S Albain
    C Osipo
    British Journal of Cancer, 2011, 105 : 796 - 806
  • [30] Catecholamine-Induced β2-Adrenergic Receptor Activation Mediates Desensitization of Gastric Cancer Cells to Trastuzumab by Upregulating MUC4 Expression
    Shi, Ming
    Yang, Zhengyan
    Hu, Meiru
    Liu, Dan
    Hu, Yabin
    Qian, Lu
    Zhang, Wei
    Chen, Hongyu
    Guo, Liang
    Yu, Ming
    Song, Lun
    Ma, Yuanfang
    Guo, Ning
    JOURNAL OF IMMUNOLOGY, 2013, 190 (11): : 5600 - 5608
12345